Ustekinumab Is Rapid-Acting and Is an Effective Long-Term Treatment for Patients with Active Psoriatic Arthritis: Real-World Evidence from the Non-interventional SUSTAIN Study

INTRODUCTION: Psoriatic arthritis (PsA) is a chronic, progressive disease that places a significant burden on patients and healthcare systems. The SUSTAIN study collected real-world evidence on long-term effectiveness, impact on quality of life, and safety of ustekinumab treatment for PsA. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Wendler, Jörg, Damann, Nils, Röcken, Marit, Teicher, Verena, Schuier, Maximilian, Hamann, Frank, Schwenke, Holger, Sieburg, Maren, Behrens, Frank
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9510084/
https://www.ncbi.nlm.nih.gov/pubmed/36066750
http://dx.doi.org/10.1007/s40744-022-00484-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9510084/
https://www.ncbi.nlm.nih.gov/pubmed/36066750
http://dx.doi.org/10.1007/s40744-022-00484-3

Ejemplares similares